Donald L. Hagan, LLC Invitae Corp Transaction History

Donald L. Hagan, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Oct 22, 2018	SELL	$7.54 - $18.31 $75,400 - $183,100	-10,000 Closed	0 $0
Q2 2018 Jul 19, 2018	SELL	$4.87 - $8.42 $52,596 - $90,936	-10,800 Reduced 51.92%	10,000 $74,000
Q1 2018 Apr 19, 2018	BUY	$4.69 - $10.05 $27,202 - $58,290	5,800 Added 38.67%	20,800 $97,000
Q3 2017 Oct 24, 2017	BUY	$8.89 - $10.4 $133,350 - $156,000	15,000	15,000 $141,000

1.92M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Donald L. Hagan, LLC, based on Form 13F filings with the SEC.

Stay updated on Donald L. Hagan, LLC with notifications on news.